{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:27:59Z","timestamp":1771036079761,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00c3\u00a8re des Affaires Sociales et de la Sant\u00c3\u00a9","doi-asserted-by":"publisher","award":["PHRC-17-0608"],"award-info":[{"award-number":["PHRC-17-0608"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ahj.2019.04.023","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:18:21Z","timestamp":1557407901000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial"],"prefix":"10.1016","volume":"214","author":[{"given":"Joachim","family":"Alexandre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Ollitrault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Olivier","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Fellahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Rozec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Cholley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Dolladille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Chequel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Allouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Legallois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Saplacan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Buklas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Beygui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Parienti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Milliez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2019.04.023_bb0005","doi-asserted-by":"crossref","first-page":"16211","DOI":"10.1016\/j.athoracsur.2013.05.050","article-title":"A contemporary cost analysis of postoperative morbidity after coronary artery bypass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care","volume":"96","author":"LaPar","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2019.04.023_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/europace\/eur208","article-title":"Post-operative atrial fibrillation: a maze of mechanisms","volume":"14","author":"Maesen","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2019.04.023_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00392-014-0754-7","article-title":"Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study","volume":"104","author":"Simopoulos","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0020","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.04.023_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.02.098","article-title":"Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement","volume":"234","author":"Jorgensen","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007558","article-title":"New-onset atrial fibrillation after coronary artery bypass graft and long-term risk of stroke: a meta-analysis","volume":"6","author":"Megens","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2019.04.023_bb0035","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.2014.9143","article-title":"Perioperative atrial fibrillation and the long-term risk of ischemic stroke","volume":"312","author":"Gialdini","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2019.04.023_bb0040","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.1996.03540040044031","article-title":"Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group","volume":"276","author":"Mathew","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2019.04.023_bb0045","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.04.023_bb0050","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jtcvs.2014.06.036","article-title":"2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures","volume":"148","author":"Frendl","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ahj.2019.04.023_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.jvca.2014.05.008","article-title":"The impact of an algorithm on the optimization of beta-blockers after cardiac surgery","volume":"29","author":"Fellahi","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ahj.2019.04.023_bb0060","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0065","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1016\/j.ijcard.2013.08.022","article-title":"Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural\/electrical remodeling","volume":"168","author":"Mayyas","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132592","article-title":"Rapid and MR-Independent IK1 activation by aldosterone during ischemia-reperfusion","volume":"10","author":"Alexandre","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2019.04.023_bb0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/FJC.0000000000000097","article-title":"Proarrhythmic effects of aldosterone during myocardial ischemia-reperfusion: implication of the sarcolemmal-KATP channels","volume":"64","author":"Alexandre","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0080","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1097\/HJH.0000000000000284","article-title":"Oxidative stress in patients affected by primary aldosteronism","volume":"32","author":"Petramala","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2019.04.023_bb0085","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1097\/HJH.0000000000001105","article-title":"Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort study","volume":"34","author":"Alexandre","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2019.04.023_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/1574884711666160714162128","article-title":"Preoperative plasma aldosterone levels and postoperative atrial fibrillation occurrence following cardiac surgery: a review of literature and design of the ALDO-POAF study (ALDOsterone for prediction of post-operative atrial fibrillation)","volume":"11","author":"Chequel","year":"2016","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0095","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/HJH.0000000000001470","article-title":"Aldoscore to predict postoperative atrial fibrillation after cardiac surgery: external validation in a Japanese cohort","volume":"35","author":"Alexandre","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.ahj.2019.04.023_bb0100","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS trial study group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.04.023_bb0105","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(02)02382-3","article-title":"Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy","volume":"40","author":"Rousseau","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.04.023_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2019.04.023_bb0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/europace\/euv366","article-title":"Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis","volume":"18","author":"Liu","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2019.04.023_bb0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1074248414557036","article-title":"Electrophysiological and antiarrhythmic properties of potassium canrenoate during myocardial ischemia-reperfusion","volume":"20","author":"Alexandre","year":"2015","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ahj.2019.04.023_bb0130","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.0000048189.58449.F7","article-title":"Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels","volume":"107","author":"Caballero","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.04.023_bb0135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.0000205831.39339.a5","article-title":"Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?","volume":"47","author":"Chai","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2019.04.023_bb0140","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0706220","article-title":"Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?","volume":"145","author":"Chai","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0145","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2019.04.023_bb0150","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","article-title":"Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction","volume":"26","author":"Milliez","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2019.04.023_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/FJC.0b013e318260e688","article-title":"Effects of spironolactone alone and in addition to a beta-blocker on myocardial histological and electrical remodeling in chronic severe failing rat hearts","volume":"60","author":"Milliez","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2010.04.024","article-title":"Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure","volume":"160","author":"Yamaji","year":"2010","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2019.04.023_bb0165","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00125-008-0972-5","article-title":"Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles","volume":"51","author":"Swaminathan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ahj.2019.04.023_bb0170","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2016.02.033","article-title":"Early aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial","volume":"67","author":"Beygui","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.04.023_bb0175","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.04.023_bb0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/CIRCEP.113.001211","article-title":"Carperitide and atrial fibrillation after coronary bypass grafting: the Nihon University working group study of low-dose HANP infusion therapy during cardiac surgery trial for postoperative atrial fibrillation","volume":"8","author":"Sezai","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319301218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319301218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:56:55Z","timestamp":1762077415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319301218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"alternative-id":["S0002870319301218"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.04.023","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}